Why in News: The World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on May 17, 2026 for an Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of Congo (DRC) — specifically Ituri Province — and Uganda (Kampala). The spread of confirmed cases to Kinshasa (~1,000 km from the epicentre) and a cross-border case in Uganda’s capital triggered the declaration. This is the 9th PHEIC declaration in WHO history (counting both Mpox declarations separately).


Outbreak Timeline and Status

Date Event
Early May 2026 Bundibugyo Ebola cases first confirmed in Ituri Province, northeastern DRC
May 14, 2026 Cross-border case confirmed in Kampala, Uganda
May 16, 2026 DRC: 8 lab-confirmed cases, 246 suspected cases, 80 suspected deaths; Uganda: 2 confirmed (1 death)
May 16, 2026 Confirmed case detected in Kinshasa (~1,000 km from Ituri epicentre)
May 17, 2026 WHO Director-General declares PHEIC under International Health Regulations (IHR) 2005

Current Case Count (as of May 16, 2026)

Country Lab-Confirmed Suspected Cases Suspected Deaths
DRC (Ituri Province) 8 246 80
Uganda (Kampala) 2 Under investigation 1 (confirmed)
DRC (Kinshasa) 1 0

The Bundibugyo Virus — Scientific Profile

Ebola Genus Classification

The genus Orthoebolaviruses (formerly Ebolavirus) comprises 6 species:

Species First Identified CFR (approx.) Vaccine Status
Zaire ebolavirus 1976, DRC ~50–90% rVSV-ZEBOV (Ervebo) — WHO prequalified 2019
Sudan ebolavirus 1976, South Sudan ~50% Candidate vaccines in trials
Bundibugyo ebolavirus 2007, Uganda ~25–40% No approved vaccine
Taï Forest ebolavirus 1994, Côte d’Ivoire Low (1 human case) None
Reston ebolavirus 1989, USA (from Philippines) Non-pathogenic in humans None
Bombali ebolavirus 2018, Sierra Leone Unknown (no human cases confirmed) None

Key Characteristics of Bundibugyo Ebolavirus

  • First identified: 2007 in Bundibugyo district, western Uganda — hence the name
  • Reservoir host: Presumed to be fruit bats (Pteropodidae family), though not definitively confirmed for Bundibugyo strain
  • Transmission: Direct contact with bodily fluids of infected humans or animals; not airborne
  • Case Fatality Rate (CFR): ~25–40% — significantly lower than Zaire strain (~50–90%) but still high
  • Incubation period: 2–21 days (same across all Ebola species)
  • No approved vaccine or specific antiviral for Bundibugyo strain (Ervebo/rVSV-ZEBOV targets only Zaire strain)

Why Bundibugyo Spread Matters

  1. No existing vaccine: The approved Merck vaccine (Ervebo) and J&J regimen (Ad26.ZEBOV/MVA-BN-Filo) cover only Zaire ebolavirus — ineffective against Bundibugyo
  2. Urban spread: Kinshasa (population ~17 million) is a megacity — urban Ebola is exponentially harder to contain than forest outbreaks
  3. Cross-border case in Kampala: Uganda’s capital is a transport hub; risk of international spread elevated
  4. Healthcare system fragility: Ituri Province (DRC) has been a conflict zone; healthcare infrastructure severely degraded

PHEIC — Mechanism and Significance

What is a PHEIC?

A Public Health Emergency of International Concern (PHEIC) is defined under Article 12 of the International Health Regulations (IHR) 2005 as:

“An extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response.”

IHR 2005 — Key Provisions

Parameter Detail
Full name International Health Regulations (2005)
Adopted 2005 (revised); came into force June 2007
Binding on 196 countries (all WHO member states + 2 additional)
Authority WHO Director-General — sole authority to declare PHEIC
Process Emergency Committee convened → DG reviews → Declaration issued
Obligations triggered States must report, coordinate response, share data; DG may recommend Temporary Recommendations
WHO’s position on travel bans Did NOT recommend blanket travel bans (consistent with IHR Article 43 — measures must be proportionate)

All PHEICs in WHO History

# Event Year Declared Status
1 H1N1 Influenza (Swine Flu) 2009 Ended 2010
2 Polio (wild poliovirus) 2014 Ongoing (as of 2026)
3 Ebola — West Africa (Zaire strain) 2014 Ended 2016
4 Zika Virus 2016 Ended 2016
5 Ebola — DRC Kivu (Zaire strain) 2019 Ended June 2020
6 COVID-19 2020 Ended May 2023
7 Mpox (Monkeypox) — 1st declaration 2022 Ended May 2023
8 Mpox — re-declared August 2024 Ongoing
9 Ebola — Bundibugyo (DRC/Uganda) 2026 Active

India’s Response

Risk Assessment

WHO assessed India’s risk from this outbreak as LOW due to:

  • No direct flight routes from Ituri Province to India
  • India’s quarantine and surveillance systems strengthened post-COVID
  • No confirmed travel links from Kampala to India in the outbreak period

Immediate Measures Activated

  • Airport thermal screening and isolation protocols activated for passengers arriving from DRC, Uganda, and affected African regions
  • Point of Entry (PoE) surveillance under IHR 2005 — India’s designated PoEs (airports, seaports, ground crossings) placed on heightened alert
  • Ministry of Health and Family Welfare (MoHFW) issued travel advisories

India’s Biosurveillance Architecture

System Full Name Role
IDSP Integrated Disease Surveillance Programme National surveillance network under NCDC; monitors epidemic-prone diseases across all states/UTs
NCDC National Centre for Disease Control Nodal agency under MoHFW; coordinates outbreak response; Delhi HQ
NVBDCP National Vector Borne Disease Control Programme Coordinates vector-borne and tropical disease surveillance
NIV National Institute of Virology Pune; India’s premier virology lab; designated civilian/ICMR BSL-4 facility; capable of handling Ebola samples
AIIMS All India Institute of Medical Sciences Designated isolation hospitals; infection prevention protocols activated

One Health Framework — Relevance

The Ebola outbreak underscores the One Health approach:

One Health is a collaborative, multisectoral, and transdisciplinary approach — working at local, regional, national, and global levels — to achieve optimal health outcomes recognising the interconnection between people, animals, plants, and their shared environment.

Dimension Ebola Context
Human health Outbreak in dense urban populations (Kinshasa, Kampala)
Animal health Fruit bats as presumed reservoir; bushmeat hunting as spillover risk
Environmental health Deforestation in DRC pushing bat populations closer to human settlements
Governance IHR 2005, WHO, FAO, OIE (WOAH) coordination needed

India is a member of the Global Health Security Agenda (GHSA) and has committed to strengthening One Health capacity under the National One Health Mission (2022).


UPSC Relevance

GS Paper 3 — Science and Technology / Health

  • Ebola classification: Orthoebolaviruses genus, 6 species, differences between strains (Zaire vs. Bundibugyo)
  • PHEIC mechanism: IHR 2005, Article 12, Emergency Committee procedure, Temporary Recommendations
  • India’s biosurveillance: IDSP, NCDC, NIV, BSL-4 labs, Point of Entry surveillance
  • One Health framework: zoonotic spillover, role of ecosystem disruption

GS Paper 2 — Governance and International Relations

  • WHO’s mandate: PHEIC as an instrument of global health governance; IHR 2005 obligations
  • Global Health Security: GHSA, Pandemic Treaty negotiations (IHR amendment process)
  • India-Africa relations: health diplomacy; vaccine equity debates; DRC conflict context
  • Travel ban controversy: IHR Article 43 — proportionate measures; WHO recommendation against blanket bans

Keywords: PHEIC, IHR 2005, Bundibugyo ebolavirus, Orthoebolaviruses, WHO, DRC, Uganda, IDSP, NCDC, NIV Pune, One Health, Zaire ebolavirus, rVSV-ZEBOV (Ervebo), BSL-4, Global Health Security Agenda.


Sources: WHO, Ministry of Health and Family Welfare, PIB, NCDC


📌 Facts Corner — Knowledgepedia

PHEIC (Public Health Emergency of International Concern):

  • Defined under Article 12, IHR 2005
  • Only the WHO Director-General can declare a PHEIC
  • Triggers mandatory international reporting and coordination obligations
  • WHO may issue Temporary Recommendations (travel, trade, health measures)
  • IHR 2005 is binding on 196 countries; came into force June 15, 2007
  • 9th PHEIC declaration (May 17, 2026) — Ebola Bundibugyo, DRC/Uganda; 2019 DRC Kivu and 2024 Mpox re-declaration are also in the count

IHR 2005 (International Health Regulations):

  • Legally binding international agreement under WHO
  • Requires states to develop core public health capacities (surveillance, response)
  • Article 43: States may take additional health measures, but they must not be more restrictive than WHO recommendations without scientific justification; blanket travel bans generally non-compliant
  • India’s IHR Focal Point: Ministry of Health and Family Welfare

Orthoebolaviruses (Ebola Genus) — 6 Species:

  • Zaire ebolavirus — most deadly (CFR ~50–90%); approved vaccine: rVSV-ZEBOV (Ervebo); first identified 1976
  • Sudan ebolavirus — CFR ~50%; vaccines in trials
  • Bundibugyo ebolavirus — CFR ~25–40%; no approved vaccine; first identified 2007, Uganda
  • Taï Forest ebolavirus — 1 human case (1994); non-fatal
  • Reston ebolavirus — non-pathogenic in humans; found in macaques from Philippines
  • Bombali ebolavirus — identified 2018, Sierra Leone; no confirmed human cases

IDSP (Integrated Disease Surveillance Programme):

  • Launched: 2004 under World Bank assistance; now under NCDC, MoHFW
  • Operates across all states/UTs via district, state, and central surveillance units
  • Monitors 33 epidemic-prone diseases including Ebola, cholera, dengue, malaria
  • Uses S (suspected), P (probable), L (laboratory-confirmed) reporting formats
  • Early Warning and Response System (EWARS) component for outbreak alerts

One Health Framework:

  • Concept: human, animal, and environmental health are interconnected and must be managed together
  • Endorsed by: WHO, FAO, UNEP, WOAH (OIE) — the “Quad” agencies
  • India: National One Health Mission launched 2022; ICAR, ICMR, DBT coordination
  • ~75% of emerging infectious diseases are zoonotic (animal-to-human spillover)
  • Ebola spillover linked to deforestation and bushmeat hunting in Central Africa

NIV Pune (National Institute of Virology):

  • India’s premier virology research institute; under ICMR
  • Located: Pune, Maharashtra
  • Houses India’s only civilian/ICMR BSL-4 (Biosafety Level 4) laboratory — capable of handling the world’s most dangerous pathogens including Ebola
  • Played pivotal role in COVID-19 diagnostics and vaccine trials
  • Can receive and test samples from suspected Ebola cases in India